Growth Metrics

Innoviva (INVA) Total Liabilities (2009 - 2026)

Innoviva posted quarterly Total Liabilities of $200000.0 for Q1 2026, little changed year-on-year from $200000.0 in Q1 2025, and little changed on a QoQ basis from $200000.0 in Q4 2025.

Innoviva (INVA) has 18 years of Total Liabilities data on file, last reported at $200000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities changed 0.0% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $200000.0 (changed 0.0% YoY), and the FY2025 full-year result was $200000.0, changed 0.0% from the prior year.
  • Total Liabilities for Q1 2026 stood at $200000.0, roughly flat from $200000.0 in the prior quarter.
  • Across five years, Total Liabilities topped out at $12.4 million in Q1 2022 and bottomed at $100000.0 in Q4 2023.
  • The 5-year median for Total Liabilities is $600000.0 (2024), against an average of $1.8 million.
  • Peak annual rise in Total Liabilities reached 700.0% in 2022, while the deepest fall reached 99.95% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $1.6 million in 2022, then tumbled by 93.75% to $100000.0 in 2023, then soared by 100.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
  • The last three Total Liabilities figures came in at $200000.0 (Q1 2026), $200000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 200,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 200,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 600,000.00
Mar 31, 2024 1.80 Mn
Dec 31, 2023 100,000.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 700,000.00
Mar 31, 2023 4.10 Mn
Dec 31, 2022 1.60 Mn
Sep 30, 2022 200,000.00
Jun 30, 2022 6.40 Mn
Mar 31, 2022 12.43 Mn
Dec 31, 2021 200,000.00
Sep 30, 2021 395.43 Mn
Jun 30, 2021 395.41 Mn
Mar 31, 2021 391.61 Mn
Dec 31, 2020 391.73 Mn
Sep 30, 2020 387.38 Mn
Jun 30, 2020 386.81 Mn
Mar 31, 2020 382.14 Mn
Dec 31, 2019 382.71 Mn
Sep 30, 2019 392.19 Mn
Jun 30, 2019 395.61 Mn
Mar 31, 2019 390.17 Mn
Dec 31, 2018 389.14 Mn
Sep 30, 2018 385.97 Mn
Jun 30, 2018 494.06 Mn
Mar 31, 2018 489.49 Mn
Dec 31, 2017 610.04 Mn
Sep 30, 2017 613.93 Mn
Jun 30, 2017 668.75 Mn
Mar 31, 2017 726.06 Mn
Dec 31, 2016 731.99 Mn
Sep 30, 2016 738.41 Mn
Jun 30, 2016 741.21 Mn
Mar 31, 2016 749.80 Mn
Dec 31, 2015 751.58 Mn
Sep 30, 2015 760.63 Mn
Jun 30, 2015 756.08 Mn
Mar 31, 2015 748.84 Mn
Dec 31, 2014 745.00 Mn
Sep 30, 2014 746.85 Mn
Jun 30, 2014 793.14 Mn
Mar 31, 2014 341.78 Mn
Dec 31, 2013 382.13 Mn
Sep 30, 2013 335.97 Mn
Jun 30, 2013 509.06 Mn
Mar 31, 2013 500.01 Mn
Dec 31, 2012 213.55 Mn
Sep 30, 2012 210.66 Mn
Jun 30, 2012 210.17 Mn
Mar 31, 2012 211.60 Mn
Dec 31, 2011 345.83 Mn
Sep 30, 2011 342.48 Mn
Jun 30, 2011 340.60 Mn
Dec 31, 2010 353.62 Mn
Dec 31, 2009 188.99 Mn